Related Experiment Video

Updated: Sep 30, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Small cell lung cancer: current therapy and promising new regimens

Scott H Okuno1, James R Jett

  • 1Mayo Clinic, Rochester, Minnesota 55905, USA. okuno.scott@mayo.edu

The Oncologist
|June 18, 2002
PubMed

Insights

This review covers current and emerging treatments for small cell lung cancer (SCLC), identifying key areas for therapeutic improvement in patient management.

Area of Science:

  • Oncology
  • Pulmonology
  • Medical Oncology

Background:

  • Small cell lung cancer (SCLC) remains a challenging diagnosis with limited treatment options.
  • Despite advances, SCLC exhibits aggressive behavior and high recurrence rates.

Purpose of the Study:

  • To provide a comprehensive overview of current SCLC management strategies.
  • To discuss promising novel therapeutic regimens for SCLC.
  • To identify unmet needs and future directions in SCLC treatment.

Main Methods:

  • Literature review of recent clinical trials and therapeutic advancements in SCLC.
  • Analysis of current standard-of-care treatments for SCLC.
  • Synthesis of emerging preclinical and clinical data on novel SCLC therapies.

Main Results:

  • Current SCLC therapies include chemotherapy, radiation, and immunotherapy, with varying efficacy.
  • Promising new regimens involve targeted therapies, antibody-drug conjugates, and novel immunotherapy combinations.
  • Significant areas for improvement exist in optimizing treatment sequencing and managing treatment resistance.

Conclusions:

  • Optimizing current SCLC treatment protocols is crucial.
  • Novel therapeutic strategies show potential to improve SCLC patient outcomes.
  • Further research is needed to address resistance mechanisms and enhance SCLC management.

More Related Videos

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.